Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Buy
69,856
+2,157
+3% +$100K 0.02% 670
2025
Q4
$2.95M Buy
67,699
+6,258
+10% +$286K 0.02% 692
2025
Q3
$2.76M Buy
61,441
+19,957
+48% +$877K 0.02% 621
2025
Q2
$1.8M Buy
41,484
+4,584
+12% +$204K 0.01% 718
2025
Q1
$1.65M Buy
36,900
+2,592
+8% +$108K 0.02% 617
2024
Q4
$1.3M Buy
34,308
+18,016
+111% +$699K 0.02% 657
2024
Q3
$661K Buy
+16,292
New +$613K 0.01% 738

Other funds holding EXC

&Partners's EXC Position: Q1 2026 in Review

&Partners increased its Exelon (EXC) stake by 3.2% in Q1 2026, buying an estimated $100K and bringing the position to 69,856 shares worth $3.42M. The position accounts for 0.02% of the portfolio, ranked #670.

&Partners first reported a position in EXC in Q3 2024 and has held it in 7 quarters since. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • &Partners held 69,856 shares of Exelon worth $3.42M as of Q1 2026.
  • &Partners bought 2,157 Exelon shares in Q1 2026, an estimated $100K.
  • Exelon made up 0.02% of &Partners's portfolio in Q1 2026, its #670 holding.
  • &Partners first reported a position in Exelon in Q3 2024 and has held it in 7 quarters since.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.